⌘K
t
NatWest Group plc purchased a total of 974,572 of its ordinary shares with a nominal value of £1.0769 each from UBS AG, London Branch on 02 March 2026, at prices ranging from 594.00 GBp to 602.80 GBp. These purchases are part of the Company's existing share buyback programme, and NatWest Group plc intends to cancel the repurchased shares. Following settlement, the Company will hold 217,789,625 Ordinary Shares in treasury and have 7,974,826,099 Ordinary Shares in issue (excluding treasury shares).
| Date | 2 Mar 2026 |
| Time | 17:28:46 |
| Category | Capital structure |
| ID | 0081V |
|
NatWest Group plc |
||||||
|
2 March 2026 |
|
|||||
|
Transaction in Own Shares |
||||||
|
NatWest Group plc (the 'Company') announces today that it has purchased the following number of ordinary shares in the Company with a nominal value of £1.0769* each ('Ordinary Shares') from UBS AG, London Branch ('UBS'). |
|
|||||
|
|
|
|
|
|
|
|
|
Aggregated information: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Date of purchase |
Number of Ordinary Shares purchased |
Highest price paid: (GBp) |
Lowest price paid: (GBp) |
Volume weighted average price paid per share (GBp) |
Venue |
|
|
02 March 2026 |
689,898 |
602.80 |
594.00 |
598.88 |
LSE |
|
|
02 March 2026 |
255,775 |
602.80 |
594.00 |
599.11 |
CHIX |
|
|
02 March 2026 |
28,899 |
601.20 |
595.00 |
599.02 |
BATE |
|
|
|
|
|
|
|
|
|
|
* Note: the nominal value of Ordinary Shares without rounding is £1.076923076923077 per share |
|
|||||
|
Such purchases form part of the Company's existing share buyback programme and were effected pursuant to the instructions issued by the Company to UBS on 16 February 2026, as announced on 16 February 2026. |
|
|||||
|
|
|
|
|
|
|
|
|
The Company intends to cancel the repurchased Ordinary Shares. |
||||||
|
|
|
|
|
|
|
|
|
Following the settlement of the above transactions, NWG will hold 217,789,625 Ordinary Shares in treasury and have 7,974,826,099 Ordinary Shares in issue (excluding treasury shares). |
|
|||||
|
|
|
|
|
|
|
|
|
Further information: |
||||||
|
|
|
|
|
|
|
|
|
Investor Relations |
|
|
|
|
|
|
|
+ 44 (0)207 672 1758 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Media Relations |
|
|
|
|
|
|
|
+44 (0)131 523 4205 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Legal Entity Identifier: 2138005O9XJIJN4JPN90 |
||||||
|
|
|
|
|
|
|
|
|
Transaction details: |
|
|
|
|
|
|
|
In accordance with Article 5(1)(b) of Regulation (EU) No.596/2014 as it applies in the UK (Market Abuse Regulation), a full breakdown of the individual trades made by UBS on behalf of the Company as part of the buyback programme relating to the Transactions is detailed in the attached: http://www.rns-pdf.londonstockexchange.com/rns/0081V_1-2026-3-2.pdf |
|
|||||
|
|
|
|
|
|
|
|